David Smith is the Vice President of Development at BioCentriq, bringing over 15 years of specialized experience in regenerative medicine and engineering. David has demonstrated a solid track record in advancing cell therapy manufacturing through his expertise in areas such as design of experiments, quality-by-design, and cross-functional leadership. In his role, David oversees Manufacturing Science & Technology (MS&T), Process Development, and Analytical Method Development, ensuring BioCentriq’s capabilities align with industry needs and maintain rigorous quality standards. Before joining BioCentriq, David was Vice President of Technical Operations at Ori Biotech, where he spearheaded the technical strategy for Ori’s first cell therapy manufacturing technology, aligning it with industry demands and supporting its adoption through a multi-faceted approach. His previous roles include Director of Research and Development at Minaris Regenerative Medicine, where he contributed to pioneering advancements in cell therapy. David holds a Ph.D. in Regenerative Medicine from Loughborough University and has served on multiple influential committees, including as chair of ARM’s Science and Technology Committee and roles within ISCT, ISO, ASME, and PDA. His extensive involvement with these organizations highlights his commitment to advancing cell therapy standards and innovation across the industry.
